Cytosorbents Corp (CTSO): Next-Year EPS Estimate 117.65%

As of 2026-06-04, Cytosorbents Corp (CTSO) has a next-year EPS growth estimate of 117.65%.

Latest revision: 103.12% → 117.65%
Revised on 2026-05-24 · estimate has held for 10 consecutive trading sessions

On 2026-05-24, analyst consensus for CTSO's next-year EPS growth shifted from 103.12% to 117.65% — a positive change of 14.53 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at -30.77%.

Current Snapshot

Sector
Healthcare
Industry
Medical Devices
EPS growth next year
117.65%
EPS growth this year
-30.77%
EPS next quarter (est)
-$0.04
Last price
$0.49

EPS Revision History

117.7%64.7%03-2906-04
Next-year EPS growth estimate · 53 observations
86.9%33.9%04-0906-04
Combined EPS growth (this year + next year) · 43 observations
DateEPS Next YEPS This YNext Q (est)Price
2026-06-04117.65%-30.77%-$0.04$0.49
2026-06-03117.65%-30.77%-$0.04$0.49
2026-06-02117.65%-30.77%-$0.04$0.48
2026-06-01117.65%-30.77%-$0.04$0.47
2026-05-31117.65%-30.77%-$0.04$0.49
2026-05-28117.65%-30.77%-$0.04$0.50
2026-05-27117.65%-30.77%-$0.04$0.49
2026-05-26117.65%-30.77%-$0.04$0.46
2026-05-25117.65%-30.77%-$0.04$0.46
2026-05-24117.65%-30.77%-$0.04$0.46
2026-05-21103.12%-23.08%-$0.04$0.46
2026-05-20103.12%-23.08%-$0.04$0.47
2026-05-19103.12%-23.08%-$0.04$0.47
2026-05-18103.12%-23.08%-$0.04$0.48
2026-05-17103.12%-23.08%-$0.04$0.50
2026-05-1473.53%-30.77%-$0.04$0.54
2026-05-1364.71%-30.77%-$0.05$0.59
2026-05-1264.71%-30.77%-$0.05$0.59
2026-05-1164.71%-30.77%-$0.05$0.63
2026-05-1064.71%-30.77%-$0.05$0.61
2026-05-0764.71%-30.77%-$0.05$0.61
2026-05-0664.71%-30.77%-$0.05$0.57
2026-05-0564.71%-30.77%-$0.05$0.61
2026-05-0464.71%-30.77%-$0.05$0.62
2026-05-0364.71%-30.77%-$0.05$0.61
2026-04-3064.71%-30.77%-$0.05$0.61
2026-04-2964.71%-30.77%-$0.05$0.64
2026-04-2864.71%-30.77%-$0.05$0.60
2026-04-2764.71%-30.77%-$0.05$0.61
2026-04-2664.71%-30.77%-$0.05$0.63

Recent News

Screen Performance

Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.

Median return since detection
+5.1%
% of tickers in the green
62%
Median return on winners
+17.5%
Large revisions captured
746

Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.

Frequently Asked Questions

What is Cytosorbents Corp's next-year EPS growth estimate?

As of 2026-06-04, Cytosorbents Corp (CTSO) has a next-year EPS growth estimate of 117.65%, based on analyst consensus.

When was the latest EPS estimate revision for CTSO?

The most recent revision occurred on 2026-05-24, when analysts adjusted the next-year EPS growth estimate from 103.12% to 117.65%.

What sector and industry does Cytosorbents Corp belong to?

Cytosorbents Corp operates in the Healthcare sector, specifically the Medical Devices industry.

How often is this EPS estimate data updated?

EPS revision data is refreshed daily from analyst consensus estimates. CTSO appears on this page because it was flagged by our daily top-EPS-revision-performer screen.

EPS revision data sourced from analyst consensus estimates, refreshed daily. Cytosorbents Corp (CTSO) appears here because it was detected by our daily top-EPS-revision-performer screen.

← All reports